Financial Engines Advisors L.L.C.

Position in BMY — Bristol Myers Squibb Co

CIK 1420473 SANTA CLARA, CA

Position in BMY

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$526,070

+$160,538 QoQ

Shares Held

9,130

+28.2% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.06%

of 13F equity value

Holder Rank

#1,507

of 2,514 holders

Holding Since

Dec 2020

12 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Financial Engines Advisors L.L.C. holds $32,908,375 across 9 Drug Manufacturers - General names. BMY ranks #7 (1.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABBV	AbbVie Inc.	83,818	$21,091,961
2	LLY	ELI LILLY & Co	2,700	$3,238,461
3	JNJ	Johnson & Johnson	12,305	$3,125,100
4	AMGN	Amgen Inc	5,295	$1,917,425
5	MRK	Merck & Co., Inc.	8,510	$1,093,535
6	NVS	Novartis AG	6,697	$1,049,553
7	BMY	Bristol Myers Squibb Co This page	9,130	$526,070
8	GILD	Gilead Sciences, Inc.	3,619	$457,224

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$526,070	9,130	+28.2%	Shares	Sole	2026-08-14
2023-12-31	$365,532	7,124	+71.9%	Shares	Sole	2024-02-13
2023-09-30	$240,517	4,144	+20.9%	Shares	Sole	2023-11-13
2022-12-31	$246,644	3,428	-10.9%	Shares	Sole	2023-02-14
2022-09-30	$273,625	3,849	-11.3%	Shares	Sole	2022-11-10
2022-06-30	$334,026	4,338	-7.1%	Shares	Sole	2022-08-11
2022-03-31	$340,977	4,669	+31.2%	Shares	Sole	2022-05-12
2021-12-31	$221,841	3,558	-20.1%	Shares	Sole	2022-02-10
2021-09-30	$263,365	4,451	-6.7%	Shares	Sole	2021-11-12
2021-06-30	$318,664	4,769	-25.4%	Shares	Sole	2021-08-12
2021-03-31	$403,779	6,396	+48.4%	Shares	Sole	2021-05-12
2020-12-31	$267,287	4,309	—	Shares	Sole	2021-02-11
No filing history on record for this holder in this stock.